Oct 22 | Apr 22 | Oct 21 | Apr 21 | Oct 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 656.00M | $ 819.00M | $ 744.00M | $ 813.00M | $ 534.00M |
Total Assets | $ 10.45B | $ 9.89B | $ 8.93B | $ 8.70B | $ 8.65B |
Total Debt | $ 1.84B | $ 2.35B | $ 2.41B | $ 2.63B | $ 2.66B |
Net Debt | $ 1.18B | $ 1.53B | $ 1.67B | $ 1.81B | $ 2.12B |
Total Liabilities | $ 5.86B | $ 5.65B | $ 5.21B | $ 5.17B | $ 5.17B |
Stockholders Equity | $ 4.59B | $ 4.23B | $ 3.72B | $ 3.53B | $ 3.48B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |